Cinnamon Extract on Menstrual Cycles in PolyCystic Ovary Syndrome (PCOS)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01483118 |
Recruitment Status :
Completed
First Posted : December 1, 2011
Results First Posted : August 2, 2017
Last Update Posted : October 3, 2017
|
Sponsor:
Rogerio A. Lobo
Collaborator:
Integrity Nutraceuticals International
Information provided by (Responsible Party):
Rogerio A. Lobo, Columbia University
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Double (Participant, Investigator); Primary Purpose: Treatment |
Condition |
Polycystic Ovary Syndrome |
Interventions |
Drug: Cinnamon Extract Dietary Supplement: Placebo |
Enrollment | 45 |
Participant Flow
Recruitment Details | Advertizing in newspaper beginning in August 2011 |
Pre-assignment Details |
Arm/Group Title | Cinnamon Extract Arm | Placebo Arm |
---|---|---|
Arm/Group Description |
Purified aqueous abstract of cinnamon in 125mg capsules Cinnamon Extract: Purified aqueous abstract of cinnamon in 125mg capsules, which would be taken orally before each meal, for a total of 1,500mg/day for 6 months. |
Placebo capsules containing ground cereal. Placebo: Placebo capsules containing ground cereal. |
Period Title: Overall Study | ||
Started | 23 | 22 |
Completed 3 Months | 15 | 11 |
Completed [1] | 11 | 6 |
Not Completed | 12 | 16 |
Reason Not Completed | ||
Lost to Follow-up | 12 | 16 |
[1]
(entire 6 months)
|
Baseline Characteristics
Arm/Group Title | Cinnamon Extract Arm | Placebo Arm | Total | |
---|---|---|---|---|
Arm/Group Description |
Purified aqueous abstract of cinnamon in 125mg capsules Cinnamon Extract: Purified aqueous abstract of cinnamon in 125mg capsules, which would be taken orally before each meal, for a total of 1,500mg/day for 6 months. |
Placebo capsules containing ground cereal. Placebo: Placebo capsules containing ground cereal. |
Total of all reporting groups | |
Overall Number of Baseline Participants | 23 | 22 | 45 | |
Baseline Analysis Population Description |
[Not Specified]
|
|||
Age, Continuous
Mean (Full Range) Unit of measure: Years |
||||
Number Analyzed | 23 participants | 22 participants | 45 participants | |
26.95
(18 to 34)
|
27.86
(18 to 38)
|
27.5
(18 to 38)
|
||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 23 participants | 22 participants | 45 participants | |
Female |
23 100.0%
|
22 100.0%
|
45 100.0%
|
|
Male |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Ethnicity (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 23 participants | 22 participants | 45 participants | |
Hispanic or Latino |
8 34.8%
|
8 36.4%
|
16 35.6%
|
|
Not Hispanic or Latino |
14 60.9%
|
13 59.1%
|
27 60.0%
|
|
Unknown or Not Reported |
1 4.3%
|
1 4.5%
|
2 4.4%
|
|
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
||||
United States | Number Analyzed | 23 participants | 22 participants | 45 participants |
23 | 22 | 45 |
Outcome Measures
Adverse Events
Limitations and Caveats
High percentage of patients lost to follow up
More Information
Results Point of Contact
Name/Title: | Roger A. Lobo M.D. |
Organization: | Columbia University, Department of OBGYN |
Phone: | 212-3056337 |
EMail: | ral35@columbia.edu |
Responsible Party: | Rogerio A. Lobo, Columbia University |
ClinicalTrials.gov Identifier: | NCT01483118 |
Other Study ID Numbers: |
AAAI1377 |
First Submitted: | November 29, 2011 |
First Posted: | December 1, 2011 |
Results First Submitted: | May 26, 2016 |
Results First Posted: | August 2, 2017 |
Last Update Posted: | October 3, 2017 |